The Marquie Group Joins Forces with City of Hope to Combat Metastatic Triple-Negative Breast Cancer
March 19, 2025 09:00 ET
|
The Marquie Group, Inc.
The Marquie Group Joins Forces with City of Hope
to Combat Triple-Negative Breast Cancer
Plus Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 27, 2025
March 19, 2025 07:30 ET
|
Plus Therapeutics Inc.
Plus Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 27, 2025
Atossa Therapeutics Announces Plans to Pursue Metastatic Breast Cancer Indication for (Z)-Endoxifen and Continued Engagement with FDA on Additional Indications
March 11, 2025 08:15 ET
|
Atossa Therapeutics, Inc.
SEATTLE, March 11, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment...
Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial
March 11, 2025 06:45 ET
|
Arvinas Inc.
– VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically meaningful improvement in progression-free survival – –...
Music of Your Life Launches Street Talk
March 07, 2025 10:59 ET
|
The Marquie Group, Inc.
TMGI subsidiary Music of Your Life launches syndicated radio program as company continues focuse on cancer awareness.
Arvinas to Participate in Upcoming Investor Conferences
March 04, 2025 16:05 ET
|
Arvinas Inc.
NEW HAVEN, Conn., March 04, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Breast Cancer Liquid Biopsy Market Research Report 2025: Global Market to Reach $1.1 Billion by 2030 - Rising Focus on Real-Time Cancer Monitoring and Personalized Treatment Drives Adoption
March 04, 2025 10:25 ET
|
Research and Markets
Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Breast Cancer Liquid Biopsy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Breast Cancer Drugs Market Size is Projected to Reach USD 80.34 Billion by 2033, Growing at a CAGR of 8.90%: Straits Research
March 04, 2025 09:50 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, March 04, 2025 (GLOBE NEWSWIRE) -- Breast cancer is the prevailing ailment in the population, predominantly affecting women who are witnessing an increase in disease...
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools
February 27, 2025 16:15 ET
|
Myriad Genetics, Inc.
Myriad Genetics announced a collaboration with Gabbi to provide an integrated offering for breast cancer risk assessment.
Breast Cancer Market Sees Rapid Growth — Key Insights and Forecasts of Different Breast Cancers for the Coming 10 Years | DelveInsight
February 27, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Breast Cancer Market Sees Rapid Growth — Key Insights and Forecasts of Different Breast Cancers for the Coming 10 Years | DelveInsight The breast...